BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27317575)

  • 21. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV.
    Abulizi G; Mijiti P; Naizhaer G; Tuerxun G; Abuduxikuer G; Zhang YY; Li H; Abulimiti T; Abudurexiti G; Aierken K; Lu L; Maimaiti A
    Cancer Med; 2021 Dec; 10(24):9022-9029. PubMed ID: 34816621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China.
    Zhao J; Zhang X; Ma J; Liu G; Yao D; Zhang W; Wang J; Wei L; Zhao Y; Zeng Y; Liao Q
    J Low Genit Tract Dis; 2012 Oct; 16(4):358-63. PubMed ID: 23023138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
    Agorastos T; Chatzistamatiou K; Moysiadis T; Kaufmann AM; Skenderi A; Lekka I; Koch I; Soutschek E; Boecher O; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Boschetti Gruetzmacher E; Tsertanidou A; Angelis L; Maglaveras N; Jansen-Duerr P
    Int J Cancer; 2017 Aug; 141(3):519-530. PubMed ID: 28470689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV.
    Li X; Xiang F; Zhao Y; Li Q; Gu Q; Zhang X; Chen Z; Zhang M; Wang J; Liu R; Kang X; Wu R
    BMC Womens Health; 2023 Aug; 23(1):411. PubMed ID: 37542333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses.
    Khan AM; Sasieni P; Singer A
    BJOG; 2015 Feb; 122(3):388-94. PubMed ID: 25088393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
    Zhao X; Cui Y; Jiang S; Meng Y; Liu A; Wei L; Liu T; Han H; Liu X; Liu F; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3432-5. PubMed ID: 25622677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Cervista® human papilloma virus high-risk test in cervical cancer screening of Xinjiang Uyghur women.
    Zhang YY; Mijit F; Abliz G; Zhang L
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):484-487. PubMed ID: 29894071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
    Del Mistro A; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Girlando S; Rizzolo R; Frayle H; Trevisan M; Sani C; Burroni E; Giorgi Rossi P; Cuzick J; Ronco G;
    Int J Cancer; 2018 Jul; 143(2):333-342. PubMed ID: 29453769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
    Katanga J; Kjaer SK; Manongi R; Pembe AB; Iftner T; Waldstrom M; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.
    Jeronimo J; Bansil P; Lim J; Peck R; Paul P; Amador JJ; Mirembe F; Byamugisha J; Poli UR; Satyanarayana L; Asthana S;
    Int J Gynecol Cancer; 2014 Mar; 24(3):576-85. PubMed ID: 24557438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J; Zhang D; Yang Z; Wang X; Wang D
    BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
    Zong LJ; Zhang YZ; Yang XS; Jiang J; Cui BX; Qiao YB; Li L; Jiang K; Zhang WJ; Kong BH; Shen K
    Asian Pac J Cancer Prev; 2015; 16(5):1907-12. PubMed ID: 25773843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.